1-4 of 4
Authors: Sigismond Lasocki
Sort by
Journal Article
Population pharmacokinetic/pharmacodynamic study suggests continuous infusion of ceftaroline daily dose in ventilated critical care patients with early-onset pneumonia and augmented renal clearance Open Access
Alexia Chauzy and others
Journal of Antimicrobial Chemotherapy, Volume 77, Issue 11, November 2022, Pages 3173–3179, https://doi.org/10.1093/jac/dkac299
Published: 05 September 2022
Journal Article
Risk factors for therapeutic failure in the management of post-operative peritonitis: a post hoc analysis of the DURAPOP trial Open Access
Philippe Montravers and others
Journal of Antimicrobial Chemotherapy, Volume 76, Issue 12, December 2021, Pages 3303–3309, https://doi.org/10.1093/jac/dkab307
Published: 30 August 2021
Journal Article
Population pharmacokinetics of daptomycin in critically ill patients with various degrees of renal impairment Free
Nicolas Grégoire and others
Journal of Antimicrobial Chemotherapy, Volume 74, Issue 1, January 2019, Pages 117–125, https://doi.org/10.1093/jac/dky374
Published: 08 October 2018
Journal Article
Is prolonged infusion of piperacillin/tazobactam and meropenem in critically ill patients associated with improved pharmacokinetic/pharmacodynamic and patient outcomes? An observation from the Defining Antibiotic Levels in Intensive care unit patients (DALI) cohort Free
Mohd H. Abdul-Aziz and others
Journal of Antimicrobial Chemotherapy, Volume 71, Issue 1, January 2016, Pages 196–207, https://doi.org/10.1093/jac/dkv288
Published: 03 October 2015
Advertisement intended for healthcare professionals
Advertisement intended for healthcare professionals